Product Information
ROSUVASTATIN CALCIUM 10 MG TAB is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.0360 per EA under NDC 27808015603. Its NADAC has been published 360 times since Nov 13, 2019.
FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808015603
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA207408FDA Approved
10/31/2016
TE Code
AB
On Market Since
1/8/2018
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 10 MG TAB has been published 360 times since Nov 13, 2019, and over the history we have for it it has declined 62.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0360 per EA |
|---|---|
| All-time high | $0.1052 (Dec 11, 2019) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0402 |
| 52-week low | $0.0360 |
| Median price | $0.0522 |
| Average price | $0.0561 |
| Largest weekly change | +24.4% (Aug 21, 2024) |
| Weeks tracked | 360 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rosuvastatin Calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 10 MG TAB, manufactured by Cranbury Pharmaceuticals, LLC, is $0.0360 per EA (NDC 27808015603), effective Sep 30, 2026.
How has the price of ROSUVASTATIN CALCIUM 10 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 10 MG TAB has declined 62.3%. It has been tracked across 360 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 10 MG TAB?
Since Nov 13, 2019, the NADAC for ROSUVASTATIN CALCIUM 10 MG TAB has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.1052 (Dec 11, 2019), with a median of $0.0522 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 10 MG TAB?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ROSUVASTATIN CALCIUM 10 MG TAB?
ROSUVASTATIN CALCIUM 10 MG TAB (NDC 27808015603) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.